Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BEDAQUILINE vs BELANTAMAB MAFODOTIN-BLMF: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BEDAQUILINE vs BELANTAMAB MAFODOTIN-BLMF: Safety Overview

Metric BEDAQUILINE BELANTAMAB MAFODOTIN-BLMF
Total FAERS Reports 3,655 150
Deaths Reported 1,137 60
Death Rate 31.1% 40.0%
Hospitalizations 1,250 36
Average Patient Age 42.2 yrs 65.9 yrs
% Female Patients 41.1% 48.3%
FDA Approval Date Dec 28, 2012 N/A
Manufacturer Janssen Products, LP N/A
Route ORAL N/A
Marketing Status Prescription Prescription